• URB597 (KDS-4103): Precision FAAH Inhibition in Neuroplastic

  2026-07-02

  URB597 (KDS-4103) delivers highly selective, robust FAAH inhibition, empowering researchers to dissect endocannabinoid signaling in neuroplasticity and neuroinflammation models. Its proven reliability in both in vivo and in vitro workflows sets a new benchmark for reproducible endocannabinoid modulation.

• hiPSC-Derived Intestinal Organoids: A New Model for Pharmaco

  2026-07-02

  This study establishes a robust, accessible protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) optimized for pharmacokinetic research. The work advances the modeling of drug absorption and metabolism in vitro, with significant implications for improving the fidelity and reproducibility of preclinical drug testing.

• DiscoveryProbe Natural Product Library Plus: Enabling Antipa

  2026-07-01

  The DiscoveryProbe Natural Product Library Plus empowers high-throughput anti-cryptosporidial screening, accelerating the identification of potent, cell-permeable bioactive compounds. This resource-centric guide covers streamlined experimental protocols, data-driven troubleshooting, and the translation of recent mechanistic findings into actionable workflows.

• Thiothixene Stimulates Macrophage Efferocytosis via Arginase

  2026-07-01

  Kojima et al. reveal that thiothixene, a typical antipsychotic agent, enhances continual efferocytosis in macrophages by upregulating Arginase 1 and the retinol-binding protein receptor Stra6L. This repurposing insight not only expands mechanistic understanding of dopamine pathway modulation but also positions thiothixene as a candidate for targeting defective cell clearance in chronic diseases.

• Açaí Extracts: Cytotoxicity and Enzyme Induction in Human He

  2026-06-30

  This study systematically evaluates the cytotoxic and enzyme-inductive potential of açaí (Euterpe oleracea) extracts in human hepatocytes. Major findings include dose- and time-dependent cytotoxicity from select extracts, but minimal impact on key cytochrome P450 enzymes or drug transporters, offering crucial insights into botanical-drug interaction risk.

• DiscoveryProbe™ L1023: Redefining MCL1 and Kinase Targeting

  2026-06-30

  Explore how the DiscoveryProbe™ L1023 Anti-Cancer Compound Library empowers advanced cancer research by enabling precise targeting of MCL1 and kinase pathways. This article uniquely integrates the latest assay insights and translational advances, setting a new benchmark for high-throughput anti-cancer compound screening.

• 1-methyl Adenosine: Precision Tools for Translational Biomar

  2026-06-29

  Explore how 1-methyl Adenosine is redefining RNA modification research and translational biomarker discovery. This thought-leadership article integrates mechanistic insights with practical strategies, highlights recent analytical advances, and offers actionable guidance for researchers moving from cellular models to clinical application.

• hiPSC-Derived Intestinal Organoids Advance Pharmacokinetic R

  2026-06-29

  This study presents a streamlined approach for generating human intestinal organoids from pluripotent stem cells, enabling robust in vitro models for drug metabolism and absorption studies. The findings support improved fidelity in pharmacokinetic research and highlight the organoids' potential to replace less predictive animal or cancer cell models.

• Capecitabine in Tumor Microenvironment Modeling: Precision A

  2026-06-28

  Explore Capecitabine’s unique activation mechanisms and apoptosis induction in the context of complex tumor microenvironments. This article reveals how N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine enables more predictive oncology assays, integrating the latest assembloid model insights.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Test

  2026-06-27

  This study introduces a patient-specific gastric cancer assembloid model that integrates matched tumor organoids and stromal subpopulations, closely replicating tumor heterogeneity and microenvironment. The approach enables nuanced exploration of drug responses and resistance, with direct implications for preclinical oncology research and personalized therapy optimization.

• LY2603618: Strategic Chk1 Inhibition for Translational Oncol

  2026-06-26

  Explore the mechanistic and translational promise of LY2603618, a selective Chk1 inhibitor, in overcoming chemoresistance in aggressive cancers. This thought-leadership article provides actionable guidance for leveraging PPP2R2A status in high-grade serous ovarian cancer and other tumor models, integrating recent evidence and advanced protocol recommendations.

• Strategic ROS Detection: Empowering Translational Redox Rese

  2026-06-26

  This thought-leadership article explores the mechanistic, experimental, and translational imperatives of precision ROS detection in living cells. By integrating the latest evidence on immunomodulatory metal complexes and leveraging advanced assay technology, it provides actionable guidance to translational researchers seeking to bridge basic redox biology with innovative therapeutic strategies.

• Praeruptorin A: Mechanistic Insights for Translational Infla

  2026-06-25

  Explore Praeruptorin A, an angular pyranocoumarin compound, as a multifaceted tool for dissecting inflammation, ferroptosis, and cancer metastasis. This article provides unique mechanistic depth and practical guidance for translational assay design.

• CD44-Driven Metabolic Rewiring in IDH-Mutant Leukemia: New D

  2026-06-25

  The reference study reveals that CD44-mediated metabolic rewiring is essential for sustaining oncometabolite production in IDH-mutant leukemia. Targeting this pathway unveils a novel therapeutic vulnerability, providing a mechanistic basis for combinatorial strategies in acute myeloid leukemia and related malignancies.

• CD8+ T Cell-Mediated Abscopal and Memory Effects in Triple C

  2026-06-24

  This study demonstrates that combining radiotherapy with dual PD-1 and TIGIT checkpoint blockade yields enhanced systemic antitumor responses and establishes robust immune memory via CD8+ T cells. The mechanistic insights highlight the interplay between M1 macrophage polarization, NF-κB activation, and long-term immunity, offering new strategies to overcome resistance in cancer immunotherapy.

14800 records 1/987 page Next 12345 下5页 Last page